Session Datesort descending
Case of Metastatic HER2+ NSCLC 01/24/2025 - 8:00am to 9:00am EST
Redefining Treatment Across the Spectrum of HR+ HER2-Expressing Metastatic Breast Cancer 01/24/2025 - 8:00am to 9:00am EST
Improving Therapeutic Approaches in SCLC & Advancing the Art of Building Phase 1 Program 02/07/2025 - 8:00am to 9:00am EST
Expert Perspectives on Emerging Data and Evolving Therapies in R/R PTCL 02/14/2025 - 8:00am to 9:00am EST
AML: An Overview Regarding Induction and Consolidation Options 02/21/2025 - 8:00am to 9:00am EST
Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches 02/28/2025 - 8:00am to 9:00am EST
Claudin 18.2 a New Target for Precision Care of Gastric and Gastroesophageal Cancers: A Case Discussion 03/07/2025 - 8:00am to 9:00am EST
Updates on Radiotherapy for Head and Neck Cancer 03/14/2025 - 8:00am to 9:00am EDT
Case of Combine Adenocarcinoma and Neuroendocrine Tumor 03/21/2025 - 8:00am to 9:00am EDT
Improving HR+/HER2- Breast Cancer Outcomes with TROP2 Antibody-Drug Conjugates 03/28/2025 - 8:00am to 9:00am EDT

Pages